Our outstanding slate of world-renowned plenary speakers will showcase the most cutting-edge advances on research and medicine, with presentations spanning the spectrum of science, clinical care, and social implications. Sessions include:
Presidential Plenary: Big Data and the Future of Endocrine Research
- Precisely Practicing Medicine from 700 Trillion Points of Data
Atul J. Butte, MD, PhD—University of California, San Francisco, San Francisco, CA, USA
- Diabetes Research in the Era of Big Data: The NIDDK Perspective
Griffin P. Rodgers, MD—National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
Presidential Plenary: The Impact of Basic Tissue Engineering and the Basic Biology of GPCRs in Emerging Therapies
- Synthetic Hydrogels as Engineered Niches in Regenerative Medicine
Andrés J. Garcia, PhD—Georgia Institute of Technology, Atlanta, Georgia, USA
- Structural Insights Into G Protein Coupled Receptor Activation: Implications for Drug Discovery
Brian K. Kobilka, MD—Stanford University, Stanford, CA, USA
Bridging the Translational Divide: Successes in Bench to Bedside
- The Incretin Revolution: Lizard Secrets and Peptide Innovation Change the Management of Diabetes
Daniel J. Drucker, MD, Lunenfeld-Tanenbaum Research Institute, University of Toronto Mt. Sinai Hospital, Toronto, Canada
- Genetic Protection from Lipid Accumulation: A Journey from Plaque to Pate
Helen H. Hobbs, MD, University of Texas Southwestern Medical Center, Dallas, TX, USA
A Deep Dive Into Development and Cancer
- Cytoskeletal Methylation: A New Cancer Target for the Epigenetic Machinery Outside the Nucleus
Cheryl L. Walker, Baylor College of Medicine, Houston, TX, USA
- Understanding Spermatogonial Stem Cells and Male Puberty at the Single-Cell and Genomic Level
Bradley R. Cairns, PhD, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA
Treating Type 2 Diabetes: New Approaches for an Old Foe
- A Hepato-Centric View of Diabetes Therapy
Adrian V. Vella, MD, FRCP, Mayo Clinic, Rochester, MN, USA
- Hormonal Hybrids for Diabetes and Obesity
Matthias H. Tschöp, MD, Helmholtz Zentrum Munchen, Germany
What Does Your Gut Tell You? How the Microbiome Modulates Metabolism
- Multi-Omics Approaches Define New Regulatory Nodes in Cardiometabolic Disease Pathogenesis
Christopher B. Newgard, PhD, Duke University, Durham, NC, USA
- The Gut Microbiome: Connections Between Nutrient Sensing, Glucose, and Disease
Tony K. T. Lam, PhD, Toronto General Hospital and University of Toronto, Canada
